News Events & Articles

Meet us at JP Morgan Chase & Co.’s 42nd Annual JP Morgan Healthcare Conference January 8, 2024 Clinakos Inc. will be at JPM2024 meeting clients, collaborators and industry colleagues to kick off a great 2024! We continue to be passionate about leveraging Patient Data and AI to further the progress in life sciences and healthcare. Reach out if you […]

How Digital Twins are Reshaping Healthcare and Pharma January 2, 2024 McKinsey & Company research indicates that 70% of C-suite technology executives at large enterprises are already exploring and investing in digital twins. Interest in digital twins, combined with rapidly advancing supportive technologies, is spurring market estimates for digital-twin investments of more than $48 billion

Happy Holidays from Clinakos December 22, 2023 Warm holiday greetings and a Happy New Year 2024 to everyone! As we bid farewell to an outstanding 2023, Clinakos Inc. celebrates our remarkable growth and continued recognition from clients, partners, and patients. Your unwavering support is deeply appreciated, and we eagerly look forward to expanding our partnership in the

Join us at Piper Sandler’s 35th Annual Healthcare Conference November 28, 2023 Join Clinakos Inc. at Piper Sandler ‘s 35th Annual Healthcare Conference in New York. Our team will be on-site from Tuesday, November 28th to Thursday, November 30th, engaging with clients and forging new partnerships. Back to News, Events & Articles

Happy Thanksgiving from Clinakos November 22, 2023 As we usher into the holiday season, Clinakos thanks and salutes our customers, partners, employees and patients for a yet another phenomenal year of growth. We remain committed to our mission of bettering human health through solutions built on the top of Integrated Patient Data and Medically Smart

September 27, 2023: Leveraging Patient Data and AI for Life Science Product Launches October 20, 2023 Over 375 industry leaders from 55+ Pharma & Biotech companies registered for our webinar “Leveraging Patient Data and AI for Life Science Product Launches”. The list included Abbott, Amgen, AstraZeneca, BioMarin Pharmaceutical Inc., Bristol Myers Squibb, Biogen, Eli Lilly and Company, Genentech, Gilead Sciences, Jazz Pharmaceuticals, Kyowa Kirin, Inc.- U.S., Reata Pharmaceuticals, Inc., The

September 21, 2023: Clinakos at ML@B Career Fair September 21, 2023 Thank you University of California, Berkeley and Machine Learning at Berkeley for inviting Clinakos Inc. to recruit for open positions at the 2023 UC Berkeley-ML@B Career Fair. It was an amazing experience to discuss #AI, #ML and #GenerativeAI with some of the smartest AI/ML

September 19, 2023 – Thoughts on EDS Patient Story September 19, 2023 Stephanie Aston, 33, died at her New Zealand home on September 1 after a public battle with Ehlers-Danlos Syndrome (EDS) — a genetic disorder she was accused of faking. Stephanie had a family history of EDS, a serious disorder associated with connective tissues.

Patient Data: Emerging Opportunities for Rare Diseases, Cell & Gene Therapies and Oncology April 26, 2023 Patient data has the potential to transform all aspects of life sciences product development and commercialization. In this session, you will hear from the CEO of a cell and gene therapy company with a late-stage investigational therapeutic for a

Clinakos Celebrates Rare Disease Day February 28, 2023 Over 300 million people worldwide are affected by rare diseases. Rare diseases impact the lives of people of all races, religions, and socio-economic status. Clinakos is proud to support the Rare Disease Patients and Life science partners in developing and commercializing cures via our unique data &